The effect of sequential administration of octreotide alone and octreotide/growth hormone simultaneously on buserelin stimulated ovarian steroid secretion in women with polycystic ovary syndrome

Clinical Endocrinology

Volumn 45, Issue 5, 1996, Pages 595-604

  Piaditis, G P ^a,b   Hatziioanidis, A H ^a   Trovas, G P ^a   Misichronis, G S ^a   Kounadi, T G ^a   Devetzaki, O A ^a   Andronis, C K ^a   Rangou, D B ^a   Chlouverakis, C S ^a  

^a IASO GENERAL HOSPITAL   (Greece)

^b KAT HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; BUSERELIN; C PEPTIDE; ESTRADIOL; FOLLITROPIN; GLUCOSE; GROWTH HORMONE; HUMAN GROWTH HORMONE; INSULIN; LUTEINIZING HORMONE; OCTREOTIDE; SOMATOMEDIN C; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029822093     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1996.00854.x     Document Type: Article

References (32)

1. Adams, J., Polson, D.W. & Franks, S. (1986) Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism British Medical Journal, 293, 355-359.
2. Adashi, E.Y., Resnick, C.E., D'Ercole, A.J., Svoboda, M.E. & Van Wyck, J.J. (1985) Insulin-like growth factors as intraovarian regulators of granulosa cells growth and function. Endocrine Reviews, 6, 400-420.
3. Barbieri, R.L, Makris, A., Randall, R.W., Daniels, G., Kistner, R.W. & Ryan, K.J. (1986) Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogensim. Journal of Clinical Endocrinology and Metabolism, 62, 904-910.
4. Barbieri, R.L., Smith, S. & Ryan, K.J. (1988) The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertility and Sterility, 50, 197-212.
5. Barnes, R.B., Rosenfield, R.L., Burstein, S. & Ehrmann, D.A. (1989) Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. New England Journal of Medicine, 320, 559-565.
6. Burghen, G.A., Givens, JR. & Kitabchi, A.E. (1980) Correlation of hyperandrogenism with hyperinsulinism in polycyctic ovarian disease. Journal of Clinical Endocrinology and Metababolism, 50, 113-116.
7. Chiodera, P., Volpi, R., d'Amato, L., Fatone, M., Cigarini, C., Fava, A., Caiazza, A., Rossi, G. & Coiro, V. (1986) Inhibition by somatostatin of LHRH-induced LH release in normal menstruating women. Gynaecology and Obstetrics Investigation, 22, 17-21.
8. Davoren, J.B. & Hsueh, A.J.W. (1986) Growth hormone increases ovarian levels of immunoreactive somatomedin C/insulin-like growth factor I in vivo. Endocrinology, 118, 888-890.
9. Dor, J., Ben-Shlomo, I., Lunenfeld, B., Pariente, C., Levran, D., Karasik, A., Seppala, M. & Mashiach, S. (1992) Insulin-like growth factor I (IGF-I) may not be essential for ovarian follicular development: Evidence from IGF-I deficiency. Journal of Clinical Endocrinology and Metabolism, 74, 539-542.
10. Dunaif, A. & Graf, M. (1989) Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycyctic ovary syndrome. Journal of Clinical Investigation, 83, 23-29.
11. Garzo, V.G. & Dorring, J.H. (1984) Aromatase activity in human granulosa cells during follicular development and the modulation by follicle-stimulating hormone and insulin. American Journal of Obstetrics and Gynaecology, 148, 657-662.
12. Glantz, S.A. (1992) Primer of Biostatistics. Third edition. McGraw-Hill International.
13. Hughes, J.N., Torresani, T., Herve, F., Martin-Pont, B., Tamboise, A. & Santarelli, J. (1991) Interest of growth hormone-releasing hormone administration for improvement of ovarian responsiveness to gonadotropin in poor responder women. Fertility and Sterility, 55, 945-951.
14. Ikuyama, S., Nawata, H., Kato, K., Karashima, T., Ibayashi, H. & Nakagaki, H. (1985) Specific somatostatin receptors on human pituitary adenoma cell membranes. Journal of Clinical Endocrinology and Metabolism, 61, 666-671.
15. Jarrett II, J.C., Ballejo, G., Trivis, J.C.M. & Spellacy, W.N. (1985) Insulin binding to human ovary. Journal of Clinical Endocrinology and Metabolism, 60, 460-463.
16. Kazer, R.R., Unterman, T.G. & Glick, R.P. (1990) An abnormality of the growth hormone/insulin-like growth factor I axis in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 71, 958-962.
17. Klibanski, A., Alexander, J.M., Bikkal, H.A., Hsu, D.W., Swearingen, B. & Zervas, N.T.T. (1991) Somatostatin regulation of glycoprotein hormone and free subunit secretion in clinically nonfunctioning and somatotroph adenomas in vitro. Journal of Clinical Endocrinology and Metabolism, 73, 1248-1255.
18. Lightman, S.L., Fox, P. & Dunne, M.J. (1986) The effect of SMS 201-95, a long-acting somatostatin analogue, on anterior pituitary function in healthy male volunteers. Scandinavian Journal of Gastroenterology, 21(suppl.119), 84-95.
19. Mason, H.D., Martikainew, H., Beard, R.W., Anyaoku, V. & Franks, S. (190) Direct gonadotrophic effect of growth hormone on oestradiol production by human granulosa cells in vitro. Journal of Endocrinology. 126, R1-R4.
20. Matthews, J.N.S., Altman, D.G., Campbell, M.J. & Royston, P. (1990) Analysis of serial measurements in medical research. British Medical Journal, 300, 230-235.
21. Millar, R.P., Klaff, L.J., Barron, J., Levitt, N.S. & Ling, N. (1982) Somatostatin-28 inhibits LHRH-stimulated gonadotrophin secretion in man. Clinical Endocrinology, 17, 103-107.
22. Nestler, J.E., Barlascini, C.O., Matt, D.W., Steingold, K.A., Plymate, S.R., Clore, J.N. & Blackard, W.G. (1989) Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycyctic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 68, 1027-1032.
23. Nestler, J.E. & Strauss, J.F. (1991) Insulin as an effector of human ovarian and adrenal steroid metabolism. Endocrinology and Metabolism Clinics of North America, 20, 807-816.
24. Owen, E.J., Shoham, Z., Mason, B.A.,Ostergaard, H. & Jacobs, H.S. (1991a) Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility and Sterility, 56, 1104-1110.
25. Owen, E.J., Torresani, T., West, C., Mason, B.A. & Jacobs, H.S. (1991b) Serum and follicular fluid insulin like growth factors I and II during growth hormone co-treatment for in vitro fertilization and embryo transfer. Clinical Endocrinology, 35, 327-334.
26. Piaditis, G.P., Kounadi, T.G., Rangou, D.B., Trovas, G.P., Kaklas, N.A., Tzonou, A.J. & Chlouverakis, C.S. (1995) A dysfunction in the growth hormone (GH)/insulin-like growth factor-1 (IGF-I) axis in women with polycystic ovarian syndrome (PCOS). Clinical Endocrinology, 42, 635-640.
27. Poretsky, L., Grigorescu, F., Seibel, M., Moses, A.C. & Flier, J.S. (1985) Distribution and characterization of insulin and insulin-like growth factor I receptors in the normal ovary. Journal of Clinical Endocrinology Metabolism, 61, 728-734.
28. Poretsky, L. & Kalin, M.F. (1987) The gonadotropic function of insulin. Endocrine Reviews, 8, 132-141.
29. Prelevic, G.M., Wurzburger, M.I., Balint-Peric, L. & Nesic, J.S. (1990) Inhibitory effect of sandostatin on secretion of luteinizing hormone and ovarian steroids in polycystie ovary syndrome. Lancet, 336, 900-903.
30. Samuels, M.H., Henry, P. & Ridgway, E.C. (1992) Effects of dopamine and somatostatin on pulsatile pituitary glycoprotein secretion. Journal of Clinical Endocrinology Metabolism, 74, 217-222.
31. Vale, W., Rivier, C., Brazeau, P., Guillemin, R., (1974) Effects of somatostatin on the secretion of thyrotropin and prolactin. Endocrinology, 95, 968-977.
32. Williams, G., Fuessl, H., Kraenzlin, M. & Bloom, S.R. (1986) Postprandial effect of SMS 201-995 on gut hormones and glucose tolerance. Scandinavian Journal of Gastroenterology, 21(suppl.119), 73-83.